Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assayKenneth Danh, Donna Grace Karp, Peter V Robinson, et al.
Nature Communications|November 29, 2025
Development of ACE2-tropic-betacoronavirus therapeutics for future pandemic preparednessAshley Utz, Matt Armbrust, Thuy-Tien T Nguyen, et al.
Biorxiv : the Preprint Server for Biology|August 31, 2021
The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamstersTimothy Carroll, Douglas Fox, Neeltje van Doremalen, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2023
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
Nature Communications|April 17, 2023
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primatesPayton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, et al.
The Journal of Infectious Diseases|September 22, 2022
Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough InfectionsNoah Brazer, Mary Kate Morris, Venice Servellita, et al.
Plos Pathogens|February 10, 2022
The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamstersTimothy Carroll, Douglas Fox, Neeltje van Doremalen, et al.
Cell|April 16, 2022
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variantsVenice Servellita, Abdullah M Syed, Mary Kate Morris, et al.
Nature Communications|July 21, 2022
Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCRKenneth Danh, Donna Grace Karp, Malvika Singhal, et al.
Nature Microbiology|January 11, 2022
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, CaliforniaVenice Servellita, Mary Kate Morris, Alicia Sotomayor-Gonzalez, et al.
Pageof 4